Here are five facts:
1. Dr. Cobbs has been a Nativis scientific and medical advisory board member since 2015.
2. He is the Gregory Foltz, M.D. Endowed Director/Neurosurgeon of the Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment at the Swedish Neuroscience Institute.
3. He earned his medical degree from the University of Alabama School of Medicine in Birmingham.
4. Dr. Cobbs completed his neurosurgical residency and neuro-oncology fellowship at the University of California, San Francisco.
5. Nativis is a clinical-stage bio-electronics company based in Seattle.
More device news:
Zimmer Biomet to present clinical data on Aspen MIS Fusion System & Timberline Systems at CNS meeting: 5 highlights
AxioMed receives Australian market approval for Freedom Viscoelastic Disc Replacement technology: 5 points
Blue Cross Blue Shield of Nebraska to cover minimally invasive sacroiliac joint fusion: 3 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
